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Abstract 
Defective germline reprogramming in Miwi2- and Dnmt3l-deficient mice results in the failure to 
reestablish transposon silencing, meiotic arrest and progressive loss of spermatogonia. Here we 
sought to understand the molecular basis for this spermatogonial dysfunction. Through a 
combination of imaging, conditional genetics and transcriptome analysis, we demonstrate that 
germ cell elimination in the respective mutants arises due to defective de novo genome 
methylation during reprogramming rather than a function for the respective factors within 
spermatogonia. In both Miwi2-/- and Dnmt3l-/- spermatogonia the intracisternal-A particle (IAP) 
family of endogenous retroviruses is de-repressed, but in contrast to meiotic cells, DNA damage 
is not observed. Instead we find that unmethylated IAP promoters rewire the spermatogonial 
transcriptome by driving expression of neighboring genes. Finally, spermatogonial numbers, 
proliferation and differentiation are altered in Miwi2-/- and Dnmt3l-/- mice. In summary, defective 
reprogramming deregulates the spermatogonial transcriptome and may underlie spermatogonial 
dysfunction. 
 
 
Introduction 
In mammals the germline is an acquired lineage derived from the proximal layer of the epiblast at the 
time of gastrulation1-6. This acquisition from the soma provides the germline with a major challenge – 
the necessity to undergo genome reprogramming to reset genomic DNA methylation patterns that 
underpin genomic imprinting and transposon silencing7-13. Genome demethylation in the mouse 
initiates at ~E9.0 as primordial germ cells (PGCs) migrate to genital ridges and is complete at 
~E13.59,14. However, some IAP copies and young transposons, as well as a few genes escape full 
demethylation12,14-16. The key executor of de novo DNA methylation is DNMT3L that recruits and 
stimulates the DNMT3 de novo DNA methyltransferases17-24. The first wave of de novo methylation is 
rather indiscriminate leading to the bulk methylation of CpG islands and transposons13. Many IAP and 
LINE1 copies escape this round of methylation and become expressed threating the genomic integrity 
of the germline through transposition13. The PIWI proteins and their associated small non-coding 
PIWI-interacting RNAs (piRNAs) neutralize this threat by simultaneously destroying cytoplasmic 
transposon mRNAs and generating secondary antisense transposon-derived piRNAs that act to guide 
the nuclear PIWI protein MIWI2 (PIWIL4) to instruct methylation by an unknown mechanism25-27. The 
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process of de novo DNA methylation is more or less complete at ~E18.516,28,29, even though the 
methylation of a few loci is finished only shortly after birth just prior gonocyte reentry into the cell 
cycle and developmental transition to spermatogonia30. 
 
The failure of male germline reprogramming in Dnmt3l- or Miwi2-deficient mice results in sterility due 
to meiotic arrest in pachytene that originates from deregulated LINE1 and IAP elements and the 
ensuing DNA damage22,27,31,32.  The loss of Dnmt3l or Miwi2 also results in the progressive loss of the 
germ cells in the adult testis27,32,33. For Miwi2-deficient mice the germ cell depletion has been shown to 
be a germ cell autonomous phenotype32. Thus, loss of either Dnmt3l or Miwi2 affects spermatogonia, 
the stem and mitotic cells of spermatogenesis. Whether the spermatogonial phenotype arises due to 
defective reprogramming or a direct function for either protein in spermatogonia remains unknown. 
There are conflicting data about Dnmt3l expression in the adult testes, however, most of the reports 
suggest that Dnmt3l transcript and protein is unlikely to be expressed in adult mouse testis22,34-38. The 
lack of Miwi2 expression was also reported for adult testis25, however, recently the Miwi2 promoter has 
been shown to be active in a subset of undifferentiated adult spermatogonia, although whether MIWI2 
protein is expressed remains unknown39. These Miwi2-expressing spermatogonia are transit-amplifying 
cells during homeostatic spermatogenesis, but also merit a population of facultative stem cells that are 
critical for injury-induced regenerative spermatogenesis39. Here we sought to understand the 
mechanism by which MIWI2 and DNMT3L contribute to the maintenance of spermatogonia and 
spermatogenesis. 
 
Results  
MIWI2 but not DNMT3L is expressed in undifferentiated spermatogonia 
The loss of spermatogonia in the Miwi2-/- and Dnmt3L-/- mice could imply that defective germline 
reprogramming in the respective mutants disrupts spermatogonial function. Alternatively, MIWI2 and 
DNMT3L could be directly expressed in spermatogonia and underpin critical cellular functions within 
these cells. To understand the expression of MIWI2 protein in the adult testis we utilized the Miwi2HA 
allele that encodes a fully functional epitope-tagged HA-MIWI240. HA-MIWI2 was detected at the 
basal compartment of the seminiferous tubule in cells with spermatogonial morphology (Fig. 1a). We 
next co-stained Miwi2HA/+ seminiferous tubules with PLZF and c-Kit, markers of undifferentiated and 
differentiating spermatogonia41,42, respectively (Fig. 1a); and found that HA-MIWI2-expressing cells 
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were PLZF positive and negative for c-Kit. To elucidate the expression of DNMT3L in the adult testis 
we generated the Dnmt3lV5 allele that encodes an N-terminal epitope-tagged V5-DNMT3L 
(Supplementary Fig. 1a, b). The introduction of the V5 epitope tag did not affect the function of 
DNMT3L protein as mice homozygous for the Dnmt3lV5 allele manifested normal spermatogenesis and 
were fertile (Supplementary Fig. 1c,d). While V5-DNMT3L could be readily detected in E16.5 fetal 
gonocytes (Supplementary Fig. 1e), it was not detected in spermatogonia or any other cell type of the 
adult testis (Fig. 1b). Additionally, the Dnmt3l transcript was very lowly expressed in juvenile 
undifferenitated spermatogonia (Supplementary Fig. 1f). In summary, MIWI2 but not DNMT3L 
protein is expressed in a subset of undifferentiated PLZF-positive spermatogonia.  
 
MIWI2 function within adult spermatogonia is not required for spermatogenic homeostasis or 
regeneration 
The fact that MIWI2 protein is expressed in a population of undifferentiated spermatogonia could 
indicate a possible direct molecular role for MIWI2 in these cells. To circumvent MIWI2’s critical role 
in germline reprogramming, conditional genetics must be employed. Miwi2 has been previously 
conditionally ablated using Stra8Cre that deletes in differentiating spermatogonia without any 
consequences to homeostatic mouse spermatogenesis43. However, Stra8Cre mediates gene deletion in 
differentiating spermatogonia just prior or upon entry into meiosis44-46 – that is after the attenuation of 
MIWI2 expression in the adult testis. We therefore utilized inducible conditional genetics to delete 
Miwi2 in adult mice. To this end we combined our Miwi2FL 27, Miwi2tdTom 39 and the tamoxifen (Tmx) 
inducible Rosa26ERT-Cre 47 alleles to generate experimental Miwi2FL/tdTom; R26ERT-Cre/+ and control 
Miwi2+/tdTom; R26ERT-Cre/+ mice. The Miwi2tdTom allele is a transcriptional reporter and a null allele of 
Miwi2, where the coding sequence of tdTomato followed by a poly(A) site has been inserted into the 
starting codon of Miwi239. The administration of Tmx to Miwi2FL/tdTom; R26ERT-Cre/+ and Miwi2+/tdTom; 
R26ERT-Cre/+ mice converts the Miwi2FL to Miwi2Null allele generating induced Miwi2 mutant (Miwi2iKO) 
and control (Miwi2CTL) mice, respectively. The presence of the Miwi2tdTom within the experimental 
design enables the isolation of Miwi2iKO and Miwi2CTL undifferentiated spermatogonia. Miwi2-
tdTomato-expressing FACS-isolated spermatogonia from Miwi2iKO mice were shown to undergo a 
complete deletion of the Miwi2FL allele as determined by genotyping and RT-qPCR (Supplementary 
Fig. 2a,b). The acute deletion, analyzed 14 days after the last Tmx injection (Supplementary Fig. 2c), 
did not impact the testicular weight, spermatogenesis, the frequency or gene expression of adult 
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undifferentiated Miwi2-tdTomato positive spermatogonia (Fig. 2a-d). We next sought to understand the 
long-term impact of Miwi2 deletion on spermatogenesis in aged cohort of Miwi2iKO and Miwi2CTL mice. 
The induced ablation did not impact spermatogenesis up to one year after deletion (Fig. 2e-g, 
Supplementary Fig. 2d), a time point where all germ cells are absent in the conventional Miwi2-/- 
mice27,32. 
The population of Miwi2-expressing spermatogonia is facultative stem cells and required for the 
efficient regenerative capacity of the testis upon injury39. Therefore, we sought to determine if MIWI2 
may function in regenerative spermatogenesis. To do so, Miwi2iKO and Miwi2CTL mice were treated 
with busulfan, a DNA alkylating agent, at a dose that kills many spermatogonial cells, induces tissue 
damage and subsequent tissue repair48. The induced loss of MIWI2 did not impact the testicular 
regeneration upon busulfan-mediated damage (Fig. 2h-j, Supplementary Fig. 2e). In conclusion, 
MIWI2 function is not required in adult spermatogonia for homeostatic or regenerative 
spermatogenesis.  
  
Defective reprogramming affects undifferentiated spermatogonia numbers, proliferation and 
differentiation in Miwi2-/- and Dnmt3l-/- mice 
The fact that MIWI2 is not required for adult spermatogonial function and DNMT3L is not detected in 
spermatogonial populations indicates that the progressive loss-of-germ-cell phenotype in the respective 
mutants originates from defective reprogramming during fetal gonocyte development. We next sought 
to understand the impact of defective reprogramming on adult spermatogonial populations in Miwi2-/- 
and Dnmt3l-/- (Supplementary Fig. 3) mice. Firstly, reduced testicular cellularity is observed in 8 weeks 
old reprogramming mutants (Fig. 3a) that arises from the meiotic arrest phenotype in both mutants. 
Undifferentiated spermatogonial populations can be identified by CD45Neg CD51Neg c-KitNeg CD9Pos 
surface expression by FACS, this population contains Gfrα1 and Miwi2-expressing cells 
(Supplementary Fig. 4) that includes the stem, facultative stem and early transit-amplifying 
spermatogonial population39,49-51. Using this surface CD45Neg CD51Neg c-KitNeg CD9Pos stain 
(Supplementary Fig. 5a), a relative increase in the frequency of undifferentiated spermatogonia is 
observed, however, with the reduced testicular cellularity there is a reduction in the absolute numbers 
of undifferentiated spermatogonia in both Miwi2-/- and Dnmt3l-/- adult mice (Fig. 3b,c). Next, we 
analyzed the Miwi2-expressing (CD45Neg CD51Neg c-KitNeg Miwi2-tdTomHi; Supplementary Fig. 5a) 
undifferentiated spermatogonia population; Miwi2-/- mice tended to have slightly lower cell number of 
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this population, whereas Dnmt3l-/- deficiency presented even lower number of these cells compared to 
the control mice (Fig. 3d,e). The expression of the Miwi2–tdTomato in CD45Neg CD51Neg c-KitPos 
(Supplementary Fig. 5a) cells identifies a nascent population of differentiating spermatogonia39. 
Interestingly, the absolute number of these differentiating spermatogonia are reduced in Miwi2-/- and 
severely depleted in Dnmt3l-/- in adult testis (Fig. 3d,f). In summary, Dnmt3l-deficiency has a greater 
impact on spermatogonia than the loss of Miwi2. Finally, we analyzed the cell cycle parameters of 
Miwi2-expressing undifferentiated spermatogonia (Supplementary Fig. 5b) and found that both Miwi2-/- 
and Dnmt3l-/- mice showed increased fractions of proliferating cells within this population (Fig. 3g,h). 
Together these results indicate that defective reprogramming affects undifferentiated spermatogonia 
cell numbers, proliferation and likely differentiation in Miwi2-/- and Dnmt3l-/- adult mice.  
 
Selective IAP de-repression without DNA damage in Miwi2-/- and Dnmt3l-/- spermatogonia 
Given that aberrant genome methylation and transposon depression is common to both reprogramming 
mutants, we aimed to understand, which elements are de-repressed in Miwi2-/- and Dnmt3l-/- 
spermatogonia. To this end, we isolated (CD45Neg CD51Neg c-KitNeg Miwi2-tdTomHi undifferentiated 
spermatogonia by FACS from wild type, Miwi2-/- and Dnmt3l-/- juvenile postnatal day 14 (P14) 
(Supplementary Fig. 5a) mice and subjected the respective isolated RNA in biological triplicates to 
strand specific RNA-seq. We selected P14 for two reasons, firstly, the spermatogenic arrest is not 
present at P14 as the pachytene stage of meiosis has not been reached and consequent confounding 
effects are minimized. At this age the loss of Miwi2 and Dnmt3l does not alter overall undifferentiated 
spermatogonial cell numbers, but does modestly impact Miwi2-tdTomato expressing undifferentiated 
and differentiating spermatogonia (Supplementary Fig. 6). Secondly, purer populations of 
spermatogonia can be isolated from P14 testis in comparison to adult mice, especially when one of the 
genotypes presents a spermatogenic arrest. Strikingly, predominantly IAP family members were 
deregulated in both Miwi2-/- and Dnmt3l-/- spermatogonia transcriptomes (Fig. 4a). In fact, the 
deregulation of transposable elements was almost identical between the respective mutant 
spermatogonia (Fig. 4b). These results were confirmed by immunofluorescence staining of wild type, 
Miwi2-/- and Dnmt3l-/- testicular cross-sections with anti-PLZF to identify undifferentiated 
spermatogonia in combination with anti-ORF1p LINE1 or anti-GAG IAP antibodies. LINE1 ORF1p 
protein was not detected in any of the genotypes, whereas IAP GAG was expressed in both Miwi2-/- 
and Dnmt3l-/- spermatogonia (Fig. 4c and d). Thus, the deregulation of IAP and its potential 
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transposition may underlie the progressive loss of spermatogonia in the reprogramming mutants. DNA 
damage is often used as a surrogate for transposition events32,52, however, we did not find evidence of 
DNA damage in spermatogonia in any of the genotypes (Fig. 4c and d). In summary, deficiency in 
Miwi2 and Dnmt3l results in nearly identical activation of the IAP family of ERVs without the 
induction of DNA damage. 
 
IAPs deregulate the Miwi2-/- and Dnmt3l-/- spermatogonial transcriptomes 
We next analyzed the expression of ENSEMBL-annotated genes in our spermatogonia RNA-seq 
datasets.  Deregulated gene expression was observed in both of Miwi2-/- and Dnmt3l-/- transcriptomes 
(Fig. 5a, Supplementary Data Set 1). However, the magnitude of gene expression changes was distinct 
between Miwi2-/- and Dnmt3l-/- transcriptomes (Fig. 5a). The deregulation of gene expression was more 
severe in the Dnmt3l-/- spermatogonial transcriptome (Fig. 5b), however, the majority of upregulated 
genes in Miwi2-/- cells were also overexpressed in Dnmt3l-/- spermatogonia (Fig. 5c).  Given that both 
factors regulate transposon silencing, we sought to understand if transposon de-repression could 
underlie this deregulated gene expression. With the manageable number of 132 upregulated genes we 
manually inspected if these upregulated transcripts in the respective mutants are associated with the 
presence of a nearby transposable element (TE). We found that a transposon acted as a promoter for the 
transcripts of 78% (35 genes) and 44% (56 genes) of the upregulated genes in Miwi2-/- and Dnmt3l-/- 
spermatogonial transcriptomes, respectively (Fig. 5d). For the 40 genes that were commonly 
upregulated in the respective mutants, a TE association of 78% was observed (Fig. 5d). Within the TE-
associated genes we examined the identity of the transposon, which was associated with the 
upregulated genes. IAPs dominated this association, where greater than 90% and 75% of upregulated 
genes in Miwi2-/- and Dnmt3l-/- spermatogonia, respectively, were driven by an IAP element (Fig. 5e, 
Supplementary Data Set 1). Other ERVs followed with LINE1 having a very minor to negligible 
association (Fig. 5e). Overall, we could define 3 classes of transcripts originating from IAPs (Fig. 5f). 
In class I the IAP was present in an intron and the TE partially overlapped with a single exon of the 
host gene. Class II was defined by an intronic IAP that drove the expression of the exons 3′of the 
insertion, such that a 5′ truncated chimeric transcript would be created. Class III was characterized by 
an upstream IAP initiating transcription prior to the first exon generating a chimeric IAP-full length 
genic transcript (Fig. 5f). Among the TE-associated upregulated genes in Dnmt3l-/- spermatogonia all 3 
class were roughly equally represented; whereas a differential split was observed Miwi2-/- 
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spermatogonia with ~46%, 29% and 26% encompassing class I to III, respectively (Fig. 5g). 
Representative loci for each of the classes and the validation of the transcripts by RT-PCR are 
presented in Fig. 5f. In summary, IAP elements greatly underlie the deregulated expression in Miwi2-/- 
and Dnmt3l-/- spermatogonial transcriptomes. 
 
Association of lowly-expressed de novo-identified transcripts with IAPs in Miwi2-/- and Dnmt3l-/- 
spermatogonial transcriptomes 
Having examined annotated genes, we next sought to understand if defective reprogramming resulted 
in the generation of novel transcripts within the spermatogonial transcriptomes. We reanalyzed the 
RNA-seq data now by de novo transcriptome assembly53 rather than mapping and quantifying reads to 
defined transcripts. The resulting datasets were filtered to include transcripts only greater than 200 bp 
in length. In this analysis, we found several hundred novel transcripts that were mostly upregulated in 
the respective mutants. The majority of the differentially expressed transcripts were expressed at very 
low levels (Fig. 6a, Supplementary Data Set 3). Interestingly, the loss of Miwi2 and Dnmt3l resulted in 
a very similar deregulation of these novel transcripts within the respective transcriptomes (Fig. 6b). 
Next we examined if the novel upregulated transcripts were associated with a transposable element. To 
this end we queried if a transposable element could be found within 1 kb from novel transcript’s 
transcription start site in comparison to a 10,000 randomly generated sized-matched transcript cohorts. 
We generated a fold enrichment by comparing the frequency of association for a given transposon 
group between random and observed (de novo-identified) transcript cohorts (Fig. 6c,d). IAPs by far 
gave the greatest and most significant fold enrichment for the novel low-expressed transcripts observed 
in Miwi2-/- and Dnmt3l-/- spermatogonial transcriptomes. In summary, not only can IAPs deregulate 
annotated genes in reprogramming-defective spermatogonia, but they are also associated with the 
expression of low-expressed transcripts.  
 
Defective de novo DNA methylation is associated with transcriptome rewiring 
Next, we wanted to explore the underlying cause of the deregulated gene expression in both Miwi2-/- 
and Dnmt3l-/- transcriptomes. Again, a common defect in both genotypes is the defective methylation 
and expression of transposable elements. The activation of IAP as promoters in spermatogonia likely 
arises due to the defective de novo DNA methylation during germline reprogramming. To test this 
hypothesis we performed whole genome bisulfite sequencing (WGBS) on P14 Dnmt3l-/- spermatogonia 
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and analyzed published data sets for wild-type and Miwi2-/- P14 spermatogonia that were purified and 
sequenced also in biological triplicates using the same methodology (Supplementary Fig. 7)40. As 
anticipated a genome-wide drastic reduction in CpG DNA methylation was observed in Dnmt3l-/- 
spermatogonia across all genomic classes, whereas Miwi2-deficency affected mostly transposable 
elements, particularly LINE1 and IAP elements (Supplementary Fig. 7). Given the repetitive nature of 
TEs, it can be difficult to get uniquely mapping reads that one can unambiguously assign to a 
transposon at a specific locus. We therefore decided to determine if there is an association between the 
deregulated loci and the differentially methylated regions (DMRs) identified in the WGBS of the 
respective genomes that are derived from uniquely mapping reads. The majority of deregulated genes 
(33/45) in Miwi2-/- spermatogonia were located within a DMR (Fig. 7a, Supplementary Data Set 4). 
Likewise, a large fraction of de novo-identified lowly-expressed transcripts were also associated with a 
DMR (Fig. 7a, Supplementary Data Set 4). To determine the significance of this enrichment, 10,000 
randomly generated sized-matched transcript cohorts were inspected to overlap given DMRs as well. 
The test revealed a positive and significant correlation of the upregulated genes and de novo-identified 
upregulated transcripts to overlap with DMRs in the Miwi2-/- spermatogonia more often than given by 
chance (Fig. 7b). Nearly all deregulated genes and transcripts were associated with DMRs in Dnm3l-/- 
spermatogonia, given that the entire Dnm3l-/- spermatogonial genome is hypomethylated (Fig. 7c,d and 
Supplementary Fig. 7). Representative examples of DMRs associated with deregulated genes is shown 
in Fig. 7e in Miwi2-/- and Dnmt3l-/- genomes. In summary, defective de novo methylation is associated 
with the aberrant gene expression in Miwi2-/- and Dnmt3l-/- spermatogonial transcriptomes.  
 
Discussion 
The progressive loss of spermatogonia in Miwi2-deficient mice is a germ cell autonomous defect27,32. 
We demonstrate that, while MIWI2 is expressed in a subset of PLZF-positive undifferentiated 
spermatogonia in the adult testis, its function is not required for homeostatic or regenerative 
spermatogenesis. Thus, the spermatogonial dysfunction in Miwi2-/- mice must be a consequence of 
defective reprogramming. Likewise, we demonstrate that DNMT3L is not detected in germ cells of the 
adult testis and thus defective reprogramming must also underlie the loss of germ cells in Dnmt3l-/- 
mice. Our DNMT3L expression data are in contrast to Liao et al., who found that DNMT3L is 
expressed in postnatal testis38. Given that we do not find expression of the protein and could only detect 
very low mRNA levels in undifferentiated spermatogonia, we think the discrepancy likely arises from 
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the antibody specificity in the other study. We found that amongst the ERVs IAPs were specifically 
deregulated with the LINE1 elements remaining silent in Miwi2-/- and Dnmt3l-/- spermatogonial 
transcriptomes. While both IAP and LINE1 elements are H3K9-Me2 by G9a (GLP) in 
spermatogonia45,52, this repression is only sufficient to silence LINE1s52. This likely reflects that the 
LTR of IAP contains a powerful promoter that can overcome G9a-mediated H3K9-Me2 and that CpG 
DNA methylation is the principal mechanism by which IAPs are silenced in spermatogonia52. 
Interestingly, DNA damage is not detected in Miwi2-/- or Dnmt3l-/- spermatogonia, which is in a stark 
contrast to abundant DNA damage observed in meiotic cells of the same genotype that manifest 
developmental arrest and apoptosis22,31,32. However, when LINE1 elements become de-repressed in the 
absence of CpG DNA methylation, G9a-mediated H3K9me2 and a functional piRNA pathway, the 
ensuing DNA damage rapidly annihilates the spermatogonial cells with the rapid loss of 
spermatogenesis52. Thus, the absence of DNA damage in Miwi2-/- and Dnmt3l-/- spermatogonia 
indicates that another mechanism other than transposon-induced DNA damage must underpin the 
spermatogonial dysfunction. Instead we find that the de-repressed IAP elements deregulate the Miwi2-/- 
and Dnmt3l-/- spermatogonial transcriptomes through inappropriately promoting gene expression and 
novel transcripts at low levels. Similarly, LINE1 and ERV elements were recently shown to deregulate 
gene expression at the zygotene stage in reprogramming mutants, although this deregulation does not 
impede developmental progression54. ERVs have been shown to act as promoters or enhancers of gene 
expression in other contexts as well55-61. For example, MuERV-L was identified as one of the first 
genes expressed during zygotic gene activation in late 1-cell-stage embryos56. Moreover, ERV LTRs 
have been co-opted to activate 2-cell-stage57,58 or 8-cell-stage embryo associated genes59. Likewise, 
ERVs have been shown to act as species-specific enhancers in the placenta60. In the examples presented 
above the genome is hypomethylated facilitating the co-opting of ERVs for the regulation of gene 
expression62-65. That said repressive mechanisms are in place to restrict ERV expression during pre-
implantation development. The lysine-specific demethylase LSD1 (KDM1A) and TRIM28a (KAP1)-
SETDB1 complex silence MuERV-L and MusD, IAP ERVs, respectively, during early embryonic 
development66-68. Lsd1-/- mice arrest at gastrulation with MuERV-L LTRs acting as promoters to drive 
expression of genes that are normally restricted to zygotic genome activation66. The loss of Trim28a or 
Setdb1 also results in early developmental arrest with deregulated of IAPs deregulating neighboring 
gene expression69-72. Indeed, Trim28- or Setdb1-deficient mESCs manifest proliferation and 
differentiation defects accompanied by reduced viability67,68,73. The aberrant gene expression in Miwi2-
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/- and Dnmt3l-/- cells encompasses not only annotated genes but also the appearance of numerous de 
novo IAP-associated transcripts. The affected loci in the reprogramming mutants are typically lowly or 
not expressed in wild type spermatogonia. We posit that the appearance of these not normally 
expressed genes and transcripts could be the basis for spermatogonial dysfunction. The deregulation of 
gene expression is more severe in Dnmt3l-/- compared to Miwi2-/- spermatogonia, which correlates with 
the more severe spermatogonial phenotype observed in Dnmt3l-/- mice. The observed transcriptomic 
deregulation in undifferentiated spermatogonia could affect basic spermatogonial stem cell properties 
such as a balanced self-renewal, cell cycle quiescence or survival that would ultimately lead to germ 
cell depletion. Indeed, a reduction in the overall numbers of undifferentiated spermatogonia that 
encompass the stem and primitive transit-amplifying spermatogenic populations is observed in the 
reprogramming mutants, coupled with the loss of spermatogonial cell cycle quiescence. Given that loss 
of quiescence in other stem cells such as the hematopoietic, neural or hair follicle stem cells has been 
associated with depletion of the stem cell pool perturbing tissue homeostasis74-77, this may be an 
important contributing factor to germ cell depletion in the respective reprogramming mutants. In 
summary, here we show that a defective germline reprogramming results in spermatogonial 
dysfunction and IAP-driven deregulation of the spermatogonial transcriptome. 
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Figure Legends 
Figure 1 MIWI2 but not DNMT3L is expressed in adult mouse undifferentiated spermatogonia. (a, b) 
Images of seminiferous tubules from Miwi2HA/+ (a) and Dnmt3lV5/+ 8 weeks old mice (b) stained as 
indicated with anti-HA, anti-V5, anti-PLZF or anti-c-Kit antibodies. 
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Figure 2 MIWI2 is not required for homeostatic or regenerative spermatogenesis. (a) Testicular weight 
of Miwi2CTL and Miwi2iKO 11-week-old mice. Error bars represent a standard deviation of the mean 
(n=6 animals). Individual data points are shown. (b) FACS analysis plots of live CD45Neg CD51Neg 
gated testicular cells from Miwi2CTL and Miwi2iKO 11-week-old mice. Numbers indicate the average 
percentage (±SD) of live CD45Neg CD51Neg c-KitNeg Miwi2-tdTomPos cells. (c) Enumeration of live 
CD45Neg CD51Neg c-KitNeg Miwi2-tdTomPos cells per testis from Miwi2CTL and Miwi2iKO 11-week-old 
mice. Error bars represent a standard deviation of the mean (n=6 animals). Individual data points are 
shown. (d) Expression scatterplots showing relative average expression of transcripts between live 
CD45Neg CD51Neg c-KitNeg Miwi2-tdTomPos CD9Pos cell populations from 11-week-old Miwi2CTL and 
Miwi2iKO mice. No significant changes in gene expression were observed. Analysis was done in 
triplicates (n=3 animals). (e) Time line for inducible Miwi2 deletion. Tamoxifen (Tmx) administration 
is depicted as black arrows and analysis time points are indicated with red bars at 6 months and 12 
months after the last tamoxifen injection. (f) Testicular weight of Miwi2CTL and Miwi2iKO mice at the 
indicated time points. Error bars represent a standard deviation of the mean. (g) Percentage of fully 
spermatogenic tubules in Miwi2CTL and Miwi2iKO at the indicated time points. Error bars represent a 
standard deviation of the mean. (h) Time line for inducible Miwi2 deletion (tamoxifen (Tmx) 
administration is depicted as black arrows), testicular damage by busulfan (Bus) administration (blue 
arrow) and the analysis time points (red bars) of 4, 8, 12 and 20 weeks after the busulfan injection are 
indicated. (i) Testicular weight of Miwi2CTL and Miwi2iKO mice over the period of 20 weeks after 
busulfan injection. Error bars represent a standard deviation of the mean. (j) Percentage of fully 
spermatogenic tubules in Miwi2CTL and Miwi2iKO mice over the period of 20 weeks after busulfan 
injection. Error bars represent a standard deviation of the mean. Number of animals (n) per time point 
in panels f, g, i, j is indicated in the figure. Source data for panel a, c, f, g, i, j are available online. 
 
Figure 3 Defective reprogramming affects undifferentiated spermatogonia numbers, proliferation and 
differentiation. (a) Total testicular cell numbers of Miwi2tdTom/+ (wild-type, WT), Miwi2tdTom/tdTom 
(Miwi2-/-) and Dnmt3l-/-; Miwi2tdTom/+ (Dnmt3l-/-) 8-week-old mice. Error bars represent a standard 
deviation of the mean. Individual data points are shown. (b) FACS plots of live CD45Neg CD51Neg 
gated testicular cells from 8-9-week-old mice of the indicated genotype. Numbers indicate the average 
percentage (±SD) of live CD45Neg CD51Neg c-KitNeg CD9Pos cells. (c) Enumeration of live CD45Neg 
CD51Neg c-KitNeg CD9Pos cells per testis from 8-9-week-old mice of the indicated genotypes (as defined 
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in panel a). Error bars represent a standard deviation of the mean. Individual data points are shown. (d) 
FACS plots of live CD45Neg CD51Neg gated testicular cells from 8-9-week-old mice of the indicated 
genotype. Numbers indicate the average percentage (±SD) of live CD45Neg CD51Neg c-KitNeg Miwi2-
tdTomPos and live CD45Neg CD51Neg c-KitPos Miwi2-tdTomPos cells. (e-f) Enumeration of live CD45Neg 
CD51Neg c-KitNeg Miwi2-tdTomPos cells (e) and CD45Neg CD51Neg c-KitPos Miwi2-tdTomPos cells (f) per 
testis from 8-9-week-old mice of the indicated genotype (as defined in panel a). Error bars represent a 
standard deviation of the mean. Individual data points are shown. Number of animals (n) in a, c, e, f is 
6 animals in WT, 7 animals in Miwi2-/-, 4 animals in Dnmt3l-/-, except panel c where 3 animals in 
Dnmt3l-/- is presented. (g) Cell cycle parameters as determined by DNA content in FACS analysis of 
live CD45Neg CD51Neg c-KitNeg Miwi2-tdTomPos gated testicular cells from 8-9-week-old mice of the 
indicated genotype.(h) Enumeration of live CD45Neg CD51Neg c-KitNeg Miwi2-tdTomPos cells from 8-9-
week-old mice of the indicated genotype (as defined in panel a) in G0-G1, S and G2-M cell cycle 
phases. Error bars represent a standard deviation of the mean (n=4 animas in WT, 6 animals in Miwi2-/- 
and Dnmt3l-/-). Individual data points are shown. Significance in a, c, e, f, h was assessed using two-
sided t-test. n.s. – not significant, * indicates a p value of < 0,01, ** indicates a p value of < 0,001, *** 
indicates a p value of < 0,0001. Source data for panels a, c, e, f, h are available online. 
 
Figure 4 Deregulation of IAP, but no DNA damage is found in Miwi2-/- and Dnmt3l-/- undifferentiated 
spermatogonia. (a) Expression scatterplots showing relative average expression (arbitrary unit (AU)) of 
transposable elements between wild-type (WT) and Miwi2-/- as well as WT and Dnmt3l-/- juvenile (P14) 
undifferentiated spermatogonia. Significantly deregulated transposable elements (p < 0,01, negative 
binomial wald test) with a fold change greater than 2 are highlighted. (b) Expression scatterplots 
showing relative average expression of transposable elements between Miwi2-/- and Dnmt3l-/- juvenile 
(P14) undifferentiated spermatogonia as presented in panel a. Analysis in a and b was done in 
triplicates (n=3 animals). (c) Images of undifferentiated spermatogonia in 8-week-old WT, Miwi2-/- and 
Dnmt3l-/- mouse testes stained with anti-LINE1 ORF1p and anti-PLZF (upper panel), anti-IAP Gag and 
anti-PLZF (middle panel) and anti-γH2AX and anti-PLZF (bottom panel) antibodies. (d) Enumeration 
of PLZFPos undifferentiated spermatogonia that are LINE1Neg or LINE1Pos (upper panel), IAPNeg or 
IAPPos (middle panel) and γH2AXNeg or γH2AXPos (bottom panel) (n>200 cells per genotype per 
staining). Source data for d are available online.  
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Figure 5 IAPs deregulate gene expression in Miwi2-/- and Dnmt3l-/- undifferentiated spermatogonia. (a) 
Expression scatterplots showing relative average expression in (arbitrary unit (AU)) of ENSEMBLE 
annotated genes between wild-type (WT) and Miwi2-/- as well as WT and Dnmt3l-/- juvenile (P14) 
undifferentiated spermatogonia. (b) Expression scatterplots showing relative average expression of 
ENSEMBLE annotated genes between Miwi2-/- and Dnmt3l-/- juvenile (P14) undifferentiated 
spermatogonia as presented in panel a. Analysis in panels a and b was done in triplicates (n=3 animals). 
Significantly deregulated genes (p < 0,05, negative binomial wald test) with a fold change greater than 
2 are highlighted in red. (c) Venn diagram indicating overlap of upregulated genes in Miwi2-/- and 
Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia. (d) Percentage of upregulated genes in Miwi2-
/-, in Dnmt3l-/- and upregulated genes that are common to both genotypes, whose expression was either 
found associated with a transposable element (TE) activity (red), or whose expression was not 
influenced by TE activity (blue). (e) Distribution of TE groups, which were identified as drivers of 
upregulated genes in Miwi2-/-, in Dnmt3l-/- and upregulated genes that are common to both genotypes as 
identified in d. (f) Examples of class I, II and III IAP driven gene expression in Miwi2-/- and Dnmt3l-/- 
juvenile (P14) undifferentiated spermatogonia with RNA-seq tracks (left) and RT-PCR validation 
(right) of the respective transcripts (uncropped gel images are shown in Supplementary Data Set 2); for 
a given transcript the y-axis is equally scaled and the median RPKM of the transcript for the indicated 
genotype is shown (g) Distribution of a class I, II and III transposable element driven gene deregulation 
in a cohort of upregulated genes in Miwi2-/-, in Dnmt3l-/- and upregulated genes that are common to 
both genotypes. 
 
Figure 6 Increase in de novo-identified lowly expressed transcripts in Miwi2 or Dnmt3l-deficient 
undifferentiated spermatogonia. (a) Expression scatterplots showing relative average expression 
(arbitrary unit (AU)) of transcripts identified by de novo transcriptome assembly between wild-type 
(WT) and Miwi2-/- as well as WT and Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia. (b) 
Expression scatterplots showing relative average expression of transcripts identified by de novo 
transcriptome assembly between Miwi2-/- and Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia 
as presented in panel a. Analysis in a and b was done in triplicates (n=3 animals). Significantly 
deregulated transcripts (p < 0,05, negative binomial wald test) with a fold change greater than 2 are 
highlighted in red. (c, d) Fold enrichment of a transposable element occurrence within 1 kb of 
significantly upregulated transcripts identified by de novo transcriptome assembly in Miwi2-/- and 
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Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia as compared to a transposable element 
occurrence with 1 kb of a 10,000 randomly generated size-matched transcript cohorts. Significance in c 
and d was assessed using two-sided t-test. All values above 1 (indicated as a vertical dashed line) 
indicate a positive enrichment. *** indicates a p value of < 0,0001. 
 
Figure 7 Defective de novo DNA methylation is associated with deregulated gene expression in Miwi2-
/- and Dnmt3l-/- undifferentiated spermatogonia. (a) Expression scatterplots showing relative average 
expression (arbitrary unit (AU)) between wild-type (WT) and Miwi2-/- juvenile (P14) undifferentiated 
spermatogonia of ENSEMBLE annotated genes (right) and transcripts identified by de novo 
transcriptome assembly (left). Indicated in the figure is the methylation status in Miwi2-/- juvenile (P14) 
undifferentiated spermatogonia of the loci giving rise to the respective transcripts. (b) Percentage of 
significantly upregulated ENSEMBLE annotated genes and upregulated transcripts identified by de 
novo transcriptome assembly in Miwi2-/- juvenile (P14) undifferentiated spermatogonia that overlap 
DMRs is presented as “observed” genes in light blue. A percentage of a 10,000 randomly generated 
size-matched transcript cohorts that overlap DMRs is presented as “random” genes in dark blue. Error 
bars represent a standard deviation of the mean. *** indicates a p value of < 0,0001 (two sided t test) 
(c) Expression scatterplots showing relative average expression between WT and Dnmt3l-/- juvenile 
(P14) undifferentiated spermatogonia of ENSEMBLE annotated genes (right) and transcripts identified 
by de novo transcriptome assembly (left) as presented in panel a. (d) Percentage of significantly 
upregulated ENSEMBLE annotated genes and upregulated transcripts identified by de novo 
transcriptome assembly in Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia that overlap DMRs 
as presented in panel b. (e) Examples of a DMR overlapping a transcription start site of IAP element in 
a case of class I, II and III gene expression upregulation. The percentage of DMR methylation in WT, 
Miwi2-/- and Dnmt3l-/- juvenile (P14) undifferentiated spermatogonia is indicated.  
 
Methods 
Mouse strains. Miwi2FL, Miwi2tdTom, Miwi2HA , Gfrα1GFP mouse alleles used were previously 
reported27,39,40,78 and maintained on a mixed 129-C57Bl/6 genetic background. Rosa26ERT-Cre allele was 
obtained from Jackson laboratory as B6;129 gt(ROSA)26Sortm1(cre/Esr1)Nat/J. 
The Dnmt3lV5 allele was created using CRISPR-Cas9 gene editing technology79. Briefly, the sequence 
encoding a BamHI restriction site and V5-tag was inserted after the starting ATG codon of Dnmt3l to 
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generate the Dnmt3lV5 allele that results in an N-terminal V5-DNMT3L fusion protein. An sgRNA (5’ 
TTCTAGCCGATTACATCAA) targeting Dnmt3l starting ATG codon was used. The presence of the 
Dnmt3lV5 allele in mice was screened by digesting PCR products amplified by primers (Fw 5’ 
CATCATCCCAGGCCCTCATA, Rv 5’ TATGGAGCAAGTGGAGGCAA) flanking Dnmt3l ATG 
with BamHI.  
Generation of the Dnmt3l– allele was achieved by recombineering with a targeting vector containing 
exons 1-7. In the targeting vector exon 2 was flanked with one loxP site at the 5’ of exon 2 and frt 
flanked neomycin resistance (frt-neoR) cassette with a second loxP site at the 3’ of exon 2 
(Supplementary Fig. 3). Linearized targeting vector was electroporated in A9 mouse embryonic stem 
cells (mESCs). Genomic DNA, extracted from individually mESC-derived neomycin resistant clones, 
was digested with BamHI and used for screening by Southern blotting80 using 3’ external probe. 
Digestion of wild-type genomic DNA with BamHI resulted in 8,9 kb fragment. Integration of loxP 
flanked exon 2 with frt-neoR cassette introduced and additional BamHI site, reducing fragment size to 
6,1 kb in targeted allele. Cre-mediated excision of exon 2 together with neoR cassette resulted in the 
Dnmt3l– allele represented by 4,2 kb fragment in Southern blotting. mESCs, containing recombined 
Dnmt3l locus were injected into C57BL/6 mouse eight-cell stage embryos. Dnmt3l-targeted mice were 
crossed with a mouse line harboring ubiquitously expressed Deleter-Cre recombinase. Cre-mediated 
recombination and excision of exon 2 together with neomycin resistance cassette resulted in the 
Dnmt3l– allele. 
No blind experiments or randomization of samples or animals were employed in this study. All mice 
used in this study were male; and bred and maintained in EMBL Mouse Biology Unit, Monterotondo, 
and subsequently in the Centre for Regenerative Medicine, Edinburgh. All procedures were done in 
accordance to the current Italian legislation (Art. 9, 27. Jan 1992, nu116) under license from the Italian 
health ministry or the UK Home Office regulations, respectively. 
 
Whole mount immunofluorescence on seminiferous tubules. Isolated 8-week-old mouse testes were 
dealbulginated and digested at 32oC for 8 minutes shaking in DMEM supplemented with Pen-Strep 
(Life technologies), NEAA (Life technologies), sodium pyruvate (Life technologies) and sodium 
lactate (Sigma) with 0,5 mg/ml collagenase (Sigma). After digestion, seminiferous tubules were 
washed with PBS and fixed in 4% paraformaldehyde (Sigma) at 4oC for 4 hours. After fixation, a few 
tubules were separated for subsequent steps of immunofluorescence. Tubules were permeabilized and 
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blocked in 0.5% Triton-X100 (Sigma), 5% normal donkey serum (Sigma), 1% BSA (Sigma) and 0.1 M 
glycine (Sigma) for 3 hours at room temperature. Primary antibody incubation was done overnight at 
room temperature in PBS with 1% BSA (Sigma). The following antibodies were used at indicated 
dilutions: rabbit monoclonal anti-HA 1:200 (Cell Signaling 3724), mouse monoclonal anti-V5 1:100 
(Invitrogen R960-25), rabbit polyclonal anti-PLZF 1:100 (Santa Cruz Biotechnology sc-22839), mouse 
monoclonal anti-PLZF 1:100 (Santa Cruz Biotechnology sc-28319), goat anti-c-Kit antibody 1:250 
(R&D Systems AF1356). Appropriate donkey anti-mouse AlexaFluor488, donkey anti-rabbit 
AlexaFluor488, donkey anti-rabbit AlexaFluor546, donkey anti-mouse AlexaFluor546 and donkey 
anti-goat AlexaFluor546 secondary antibodies (Life technologies) were used in a dilution 1:1000 and 
incubated for 1 hour at room temperature in PBS with 1% BSA (Sigma) and 0,1% Triton X-100 
(Sigma). DAPI (5 μg/μl) (Life technologies) was used to stain DNA. Samples were mounted with 
ProLong Gold antifade reagent (Life technologies). Leica TCS SP5 and SP8 confocal microscopes 
were used to acquire images. After acquisition images were processed with ImageJ and Adobe 
Photoshop CS5 computer programs. All images corresponding to the same experiment were acquired 
and processed afterwards applying the same settings. Testes from 2 adult mice were used per each 
genotype analyzed as biological duplicates. All the data was collected in 2 independent 
immunofluorescence experiments. Five images were acquired per each biological replicate per 
genotype. 
 
Inducible Miwi2 deletion and histological analysis. To evaluate the impact of Miwi2 deletion on 
spermatogenesis, 8-week-old Miwi2Tom/+; Rosa26ERT-Cre (Miwi2CTL) and Miwi2Tom/FL; Rosa26ERT-Cre 
(Miwi2iKO) mice were administered with 10 mg/ml tamoxifen solution injected intraperitoneally with a 
dose of 75 mg/kg every second day until a total of 5 injections per animal were reached. To evaluate 
the impact of Miwi2 deletion on testicular regeneration, 8-week-old Miwi2CTL and Miwi2iKO mice were 
administered with tamoxifen as described previously and then injected with 4 mg/ml solution of 
busulfan intraperitoneally with a singular dose of 10 mg/kg ten days after the last tamoxifen injection. 
At the time points described in the text and figure legends mice were sacrificed and testicular weight 
recorded. Testes were fixed in Bouin’s fixative (Sigma) overnight at 4oC and paraffin embedded. A 
half of tamoxifen or tamoxifen and busulfan injected mouse testis was sectioned taking six 8-µm-thick 
representative sections throughout the length and stained with hematoxylin and eosin using routine 
methods. A picture of whole testis cross-section was reconstructed using the mosaic function of the 
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Leica Microdissector 7000 microscope (LMD 7000). Total number and number of fully spermatogenic 
tubules in cross-sections were counted. An average of fully spermatogenic tubules in a testis of an 
animal of a respective genotype in a group was calculated.  
 
Spermatogonial cell isolation. Isolated adult (Fig. 2,3, Supplementary Fig. 4) or postnatal day 14 
(P14) (Fig. 4-7, Supplementary Fig. 5,6) testes from mice of the respective genotypes that also carried 
the Miwi2tdTom transcriptional allele in heterozygosity were dealbulginated and digested with 
collagenase (0,5 mg/ml, Sigma) at 32oC for 10 minutes shaking in DMEM media (Life technologies) 
supplemented with Pen-Strep (Life technologies), NEAA (Life technologies), sodium pyruvate (Life 
technologies) and sodium lactate (Sigma). After digestion seminiferous tubules were washed with 
DMEM and single cell suspension was prepared by further digesting seminiferous tubules with 0,05% 
trypsin (Life technologies) at 32oC for 8-10 minutes shaking. After digestion trypsin was neutralized by 
adding FCS (PAN Biotech), also DNase (Sigma) was added to a final concentration of 0,05 mg/ml. 
Cells were spun and resuspended in PBS with 3% FCS. For sorting and/or analysis of Miwi2CTL, 
Miwi2iKO,  Miwi2tdTom/+, Miwi2tdTom/tdTom and Dnmt3l-/-; Miwi2tdTom/+ mice testicular single cell 
suspension was stained with the following antibodies: c-Kit-PE-Cy7 1:800 (eBioscience 25-1171), 
CD45-biotin 1:400 (eBioscience 13-0451), CD51-biotin 1:100 (Biolegend 104104), streptavidin-
qDot605 1:50 (eBioscience 93-4317), CD9-FITC 1:50 (eBioscience 11-009) in PBS with 3% of FCS 
and 0,01% sodium azide (Sigma). SYTOX Blue (Life technologies) was used as a living dye. For the 
analysis of Miwi2td/Tom+; Gfra1GFP/+ mice single cell suspension was prepared and stained as described 
above, except for the use of CD9-FITC antibody, where CD9-APC antibody was used instead 
(eBioscience 17-0091-82). A target population was selected by excluding cell doublets, CD45Pos and 
CD51Pos cells by initially choosing to analyze cells with low side scatter and negative for live cell dye 
SYTOX Blue. Among live CD45Neg and CD51Neg cells, a target population was identified as c-KitNeg 
and having a live fluorescence of tdTomato (Miwi2-tdTomPos) and being CD9Pos (Supplementary Fig. 
4,5a). Cells were sorted with an 85 μm nozzle using a FACSAria II SORP (BD Biosciences), reaching 
98% of purity. The data was recorded using BD FACSDIVA software and later analyzed using FlowJo 
software. For cell cycle analysis of Miwi2tdTom/+, Miwi2tdTom/tdTom and Dnmt3l-/-; Miwi2tdTom/+ mice 
testicular single cell suspension was stained with the following antibodies: c-Kit-PE-Cy7 1:800 
(eBioscience 25-1171), CD45-biotin 1:400 (eBioscience 13-0451), CD51-biotin 1:100 (Biolegend 
104104), streptavidin-APC 1:400 (Life technologies S21374) in PBS with 3% of FCS and 0,01% 
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sodium azide (Sigma) after incubating with 0,01 µg/µl Hoescht 33342 (Sigma) at 32oC for 20 minutes 
shaking. 7AAD (7-aminoactinomycin) (Sigma) was used as a living dye. Target population was 
selected as described above (Supplementary Fig. 5b). Cells were analyzed with FACSAria II SORP 
(BD Biosciences), the data was recorded using BD FACSDIVA software and later analyzed using 
FlowJo software. 
 
Immunofluorescence. Testes were freshly embedded into OCT compound (Sakura), 8-μm-sections 
were cut, fixed in 4% paraformaldehyde (Sigma) 10 minutes at room temperature and then 
permeabilized for 10 minutes at room temperature in 0.1% Triton-X100 (Sigma). Subsequently 
sections were blocked for 30 minutes at room temperature in 10% normal donkey serum (Sigma), 1% 
BSA (Sigma) and 0.1 M glycine (Sigma). Primary antibody incubation was done overnight at 4oC in 
the blocking buffer. The following antibodies were used at indicated dilutions: mouse monoclonal anti-
PLZF antibody 1:100 (Calbiochem OP128), rabbit L1 ORF1p 1:50052, rabbit anti-IAP Gag 1:500 (B. 
Cullen), rabbit polyclonal anti-γH2AX antibody 1:500 (Bethyl Laboratories IHC-00059), mouse 
monoclonal anti-V5 1:200 (Invitrogen R960-25). Appropriate donkey anti-mouse AlexaFluor488, 
donkey anti-rabbit AlexaFluor546 secondary antibodies (Life technologies) were used in a dilution 
1:1000. DAPI (5 μg/μl) (Life technologies) was used to stain DNA. Samples were mounted with 
ProLong Gold antifade reagent (Life technologies). Leica TCS SP5 confocal microscope was used to 
acquire images. After acquisition images were processed with ImageJ and Adobe Photoshop CS5 
computer programs. All images corresponding to the same experiment were acquired and processed 
applying the same settings. For evaluation of L1 ORF1p, IAP Gag and γH2AX expression in Miwi2- 
and Dnmt3l-deficient, as well as in wild-type undifferentiated spermatogonia, testes from three adult 
mice were used per each genotype as biological triplicates. All the data was collected in three 
independent immunofluorescence experiments. On average 20 images were acquired for each 
biological replicate per genotype and >230 PLZF expressing cells (approx. 80-100 per biological 
replicate) were manually inspected for expression of L1 ORF1p, IAP Gag and γH2AX expression in 
each genotype group. E16.5 fetal testes were used for immunofluorescence to validate V5-DNMT3L 
expression. 
 
RT-(q)PCR. Sorted spermatogonia, as described above, from mice of respective genotypes, were lyzed 
in 1ml of QIAzol (QIAGEN). Extracted total RNA was used for reverse transcription reaction with 
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SuperScript II or SuperScript IV first-strand cDNA synthesis system using random primers (Invitrogen) 
according to manufacturer‘s recommendations. cDNA from sorted adult spermatogonia was used for 
qPCR, which was performed using 2x SYBR green I master (Roche) in biological and technical 
triplicates and run on a LightCycler 480 (Roche). An expression level of a target transcript was 
normalized to the expression level of GAPDH gene using 2-ΔΔCt method.  
cDNA from sorted postnatal day 14 spermatogonia was used to validate expression of selected genes in 
Miwi2- and Dnmt3l-deficient cells. 
Primers used: 
GAPDH_Fw 5‘TGTCGTGGAGTCTACTGGTG 
GAPDH_Rv 5‘TTCACACCCATCACAAACAT 
Miwi2_Ex16_Fw 5‘AGCGGCTGATATTGCAGATT 
Miwi2_Ex17_Rv 5‘GCTTCAAGGCATTGTCATCA 
Bhmt2_Ex8_Fw 5’TGTGTGTTGCTTGTCATGTTT 
Bhmt2_IAP_Rv 5’GAAGGCAGAGCACATGGAGT 
Poteg_Ex10_Fw 5’AACTGTGCTGGCAATTCACC 
Poteg_Ex13-14_Rv 5’CCGATTCTCTCAAAGGGTGG 
Ky_Ex2-3_Fw 5’CGACAACCAAGGAAACTTGC 
Ky_Ex5_Rv 5’GGGCATCTTTCCCTCCAG 
   
Gene expression analysis. Total RNA extracted from sorted spermatogonial cells from tamoxifen 
injected adult Miwi2CTL and Miwi2iKO mice at the time point noted in the text and figure legends was 
subjected to microarray gene expression analysis with GeneChip Mouse Gene 2.0 Array (Affymetrix). 
Three biological replicates were generated per genotype to ensure adequate power to detect statistically 
significant differences between the respective genotypes. Microarray data was normalized using the 
Robust Multi-array Average (RMA) expression measure. The linear model was then used to fit the data 
with the R package, limma. limma powers differential expression analyses for RNA-sequencing and 
microarray studies81. 
 
RNA sequencing. Total RNA extracted from sorted juvenile P14 spermatogonial cells were subjected 
to DNase treatment and rRNA removal using RiboGone (Clonethech) protocol according to 
manufacturer’s instructions. DNase-treated and rRNA depleted RNA was subjected to library 
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preparation using SMARTer Stranded RNA-Seq Kit (Clonetech) according to manufacturer’s 
instructions. 10 ng of total RNA was used as an input for library preparation. Libraries were sequenced 
using Illumina HiSeq2000 platform. 
 
RNA sequencing data analysis. Paired FASTQ files for each replicate were mapped against the 
mouse genome (GRCm38) using the ENSEMBL version 79 GTF annotation using HiSat2 (2.0.4) 
for known splice sites. Mapped reads were quantified into count data for each sample using htseq-count 
(0.6.1). This count table was processed and normalized using DESeq2 for differential expression 
analysis across conditions in R/BioConductor. For novel transcript analysis, Trinity (2.2.0) was run on 
the raw FASTQ paired end data using default parameters for paired end data. Detected novel transcripts 
(FASTA) for each sample were compared against known ENSEMBL transcripts using BLASTN (E<= 
1e-10). Sequences with BLASTN hits covering more than 60% of their total length were discarded, 
together with sequences less than 200 nt. Each recovered novel sequence was then mapped back to the 
mouse genome using exonerate (2.40) and converted to GTF format. These novel transcripts were 
added back to a unified GTF file containing both ENSEMBL and Novel transcripts and remapped 
using HiSat2 (as above) and converted to counts using htseq-count for subsequent analysis. 
 
Transposable element expression analysis in RNA sequencing data. For TE analysis, the raw 
FASTQ files were mapped against known repeats from RepBase rodent repeats (rodrep) using Bowtie2 
in paired-end mode. The repeat family and subfamily count for each sample was summed for each 
replicate into a master table of repeat hits per sample. This table of repeat counts was processed for 
differential repeat expression as above using DESeq2 in R/BioConductor. For repeat enrichment 
analysis of differentially expressed genes, each gene list was tested for the presence of repeats based on 
ENSEMBL RepeatMasker derived using bedtools intersect for genes against repeat BED files. The 
total number of hits to each repeat family was compared for enrichment against 10,000 random gene 
lists of the same size. 
 
Statistics used in this study. The negative binomial wald test was used for differential expression of 
both known and novel transcripts using DESeq2. For repeat and DMR enrichment a two-sided t-test 
was performed (R/Bioconductor) for repeat or DMR presence in each gene list versus 10,000 random 
cohorts of genes of the same size. Elsewhere a two-sided t-test was used. 
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Whole genome bisulfite sequencing and alaysis was performed on genomic DNA isolated from 
spermatogonia isolated from P14 testes as described in 40, except that in 50 adjacent CpG running 
window probes percentage of methylation was calculated for probes that contained at least 3 reads per 
CpG. 
 
Data availability 
Mouse gene expression microarray data have been deposited in www.ebi.ac.uk/arrayexpress with 
accession code E-MTAB-6612. Gene expression data have been deposited in www.ebi.ac.uk/ena with 
the accession code PRJEB23111. WGBS data that support the findings of this study have been 
deposited in www.ebi.ac.uk/arrayexpress with the accession code E-MTAB-6202 and E-MTAB-
556140. Source data for Figures 2a,d,f,g,i,j, 3a,c,e,f,h, 4d, Supplementary Figures 1c, 3c, 6a,c,e,f are 
available online. Figures 5a,e,f, 6a, Supplementary Figure 7a have associated data sets available with 
the study online.  Other data that support the findings of this study are available from the corresponding 
author upon reasonable request. 
 
Code availability 
Computer code used to analyse RNA sequencing and whole genome bisulfite sequencing data is 
available upon request from A.J.E. and R.V.B. or W.R., respectively.  
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